Home › Funds › Cormorant Asset Management, LP › ODTX
Cormorant Asset Management, LP position in ODTX
ODYSSEY THERAPEUTICS INC · Health Care
Cormorant Asset Management, LP reported holding 125,000 shares of ODTX (ODYSSEY THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.8M, representing 0.20% of its reported portfolio and ranking #47 among its reported holdings. Cormorant Asset Management, LP has disclosed ODTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's ODTX position evolved
Cormorant Asset Management, LP first disclosed a stake in ODTX in Q2 2026 at 175,000 shares (US$3.3M). Across 2 filings, Cormorant Asset Management, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 125,000 shares valued at US$2.8M — a reduction of -50,000 shares quarter over quarter.. Notable position changes include a 29% trim in Q3 2026 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 175.00K | $3.27M | New |
| Q3 2026 | 125.00K | $2.78M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ODTX and 13F data
ODTX (ODYSSEY THERAPEUTICS INC) is a Health Care company. 75 other funds we track also report a position in ODTX — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$84.3M), TPG GP A, LLC (US$82.0M), Lightspeed Management Company, L.L.C. (US$80.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ODTX
- SR ONE CAPITAL MANAGEMENT, LP 3.79M sh · $84.32M · Q3 2026
- TPG GP A, LLC 3.69M sh · $82.00M · Q3 2026
- Lightspeed Management Company, L.L.C. 3.61M sh · $80.18M · Q3 2026
- ORBIMED ADVISORS LLC 3.00M sh · $66.69M · Q3 2026
- Sanofi 1.99M sh · $44.22M · Q3 2026
- MPM BioImpact LLC 1.29M sh · $28.64M · Q3 2026
- Affinity Asset Advisors, LLC 1.26M sh · $28.00M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.05M sh · $23.25M · Q3 2026
- Sands Capital Alternatives, LLC 875.00K sh · $19.44M · Q3 2026
- Hillhouse Capital (HHLR Advisors) 831.66K sh · $18.48M · Q3 2026
- General Catalyst Group Management, LLC 810.27K sh · $18.00M · Q3 2026
- Foresite Capital Management V, LLC 729.60K sh · $16.21M · Q3 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held ODTX?
Cormorant Asset Management, LP has disclosed ODTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Cormorant Asset Management, LP's current position in ODTX?
As of Q3 2026, Cormorant Asset Management, LP holds 125.00K shares of ODTX (ODYSSEY THERAPEUTICS INC), valued at $2.78M, representing 0.20% of its reported portfolio and ranking #47.
Has Cormorant Asset Management, LP been buying or selling ODTX?
In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP reduced its position in ODTX.
Which other funds hold ODTX?
Other major institutional holders of ODTX include SR ONE CAPITAL MANAGEMENT, LP, TPG GP A, LLC, Lightspeed Management Company, L.L.C., among 75 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.